Skip to content Skip to footer
Professor

Timothy Mercer

Email: 
Phone: 
+61 7 334 64300

Overview

Background

Professor Tim Mercer is Founding Director of the BASE mRNA Facility at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, and an NHMRC Leadership Fellow.

BASE is a national NCRIS-supported facility that designs, manufactures and tests mRNA-LNP medicines. Its production facility at the Translational Research Institute supplies mRNA-LNPs to around 120 research laboratories across Australia, and its new clinical manufacturing suites will enable clinical-grade mRNA production. Tim's team develops new methods for mRNA design, manufacture and quality control, including the mRNArchitect design software, a single-step isothermal mRNA synthesis reaction, and nanopore sequencing for mRNA quality control.

Tim trained in computational biology and genomics, and his early work contributed to the discovery of long non-coding RNAs. He has held positions at the Broad Institute, the Max Planck Institute in Dresden, the Centre for Genomic Regulation in Barcelona and the Garvan Institute. He has translated his research into clinical tools, including targeted RNA sequencing, now a first-line diagnostic for cancer fusion genes, and synthetic RNA and DNA controls for clinical genome sequencing.

Tim serves on the Executive Board of the Alliance for mRNA Medicines and chairs its Asia-Pacific Committee.

Availability

Professor Timothy Mercer is:
Available for supervision

Qualifications

  • Doctor of Philosophy, The University of Queensland

Research interests

  • mRNA design and manufacture

    Developing new methods to design and manufacture mRNA medicines. This includes mRNArchitect, software for designing optimised mRNA sequences, and a single-step isothermal reaction that simplifies mRNA synthesis. We apply these tools to build mRNA vaccines and therapies with Australian research and clinical partners.

  • mRNA quality control and reference standards

    Using nanopore sequencing to measure mRNA sequence, integrity, 5' capping and poly(A) tails during manufacture. We develop reference standards with partners including NIST to support consistent quality control and regulation of mRNA medicines.

  • Targeted mRNA-LNP delivery

    Developing lipid nanoparticles that deliver mRNA to specific cell types, including immune cells for in vivo cell therapies.

  • RNA genomics and long-read sequencing

    Studying how the human genome is transcribed using long-read and targeted RNA sequencing. Earlier work contributed to the discovery of long non-coding RNAs and developed targeted RNA sequencing, now a clinical diagnostic for cancer fusion genes.

Research impacts

Tim's research has been translated into clinical diagnostics, industry standards and national manufacturing capability.

  • Cancer diagnostics. Tim developed targeted RNA sequencing, which was commercialised with Roche and is now a first-line diagnostic for cancer fusion genes. He raised philanthropic funding to establish the first targeted RNA sequencing fusion-gene test for Australian cancer patients at St Vincent's Hospital, Sydney.
  • Genome sequencing standards. Tim developed synthetic RNA and DNA controls for clinical genome sequencing, worked with the US FDA on regulatory recommendations for sequencing-based tests, and co-founded Sequins Pty Ltd to commercialise these standards.
  • Sovereign mRNA capability. As Founding Director of BASE, Tim established a national facility that supplies mRNA-LNPs to around 120 research laboratories across Australia, helping researchers develop new mRNA vaccines and therapies.
  • mRNA quality control. His team's nanopore sequencing methods for mRNA quality control are used by mRNA manufacturers and are informing international reference standards developed with NIST.

Works

Search Professor Timothy Mercer’s works on UQ eSpace

105 works between 2007 and 2026

41 - 60 of 105 works

2020

Journal Article

Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody

Singh, Mandeep, Jackson, Katherine J. L., Wang, Jing J., Schofield, Peter, Field, Matt A., Koppstein, David, Peters, Timothy J., Burnett, Deborah L., Rizzetto, Simone, Nevoltris, Damien, Masle-Farquhar, Etienne, Faulks, Megan L., Russell, Amanda, Gokal, Divya, Hanioka, Asami, Horikawa, Keisuke, Colella, Alexander D., Chataway, Timothy K., Blackburn, James, Mercer, Tim R., Langley, David B., Goodall, D. Margaret, Jefferis, Roy, Gangadharan Komala, Muralikrishna, Kelleher, Anthony D., Suan, Dan, Rischmueller, Maureen, Christ, Daniel, Brink, Robert ... Reed, Joanne H. (2020). Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody. Cell, 180 (5), 878-894.e19. doi: 10.1016/j.cell.2020.01.029

Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody

2019

Journal Article

Chiral DNA sequences as commutable controls for clinical genomics

Deveson, Ira W., Madala, Bindu Swapna, Blackburn, James, Barker, Chris, Wong, Ted, Barton, Kirston M., Smith, Martin A., Watkins, D. Neil and Mercer, Tim R. (2019). Chiral DNA sequences as commutable controls for clinical genomics. Nature Communications, 10 (1) 1342, 1-13. doi: 10.1038/s41467-019-09272-0

Chiral DNA sequences as commutable controls for clinical genomics

2019

Journal Article

Diagnosis of fusion genes using targeted RNA sequencing

Heyer, Erin E., Deveson, Ira W., Wooi, Danson, Selinger, Christina I., Lyons, Ruth J., Hayes, Vanessa M., O’Toole, Sandra A., Ballinger, Mandy L., Gill, Devinder, Thomas, David M., Mercer, Tim R. and Blackburn, James (2019). Diagnosis of fusion genes using targeted RNA sequencing. Nature Communications, 10 (1) 1388, 1-12. doi: 10.1038/s41467-019-09374-9

Diagnosis of fusion genes using targeted RNA sequencing

2019

Journal Article

Use of synthetic DNA spike-in controls (sequins) for human genome sequencing

Blackburn, James, Wong, Ted, Madala, Bindu Swapna, Barker, Chris, Hardwick, Simon A., Reis, Andre L. M., Deveson, Ira W. and Mercer, Tim R. (2019). Use of synthetic DNA spike-in controls (sequins) for human genome sequencing. Nature Protocols, 14 (7), 2119-2151. doi: 10.1038/s41596-019-0175-1

Use of synthetic DNA spike-in controls (sequins) for human genome sequencing

2019

Journal Article

TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: a focus on Africa

Blackburn, James, Vecchiarelli, Stefano, Heyer, Erin E., Patrick, Sean M., Lyons, Ruth J., Jaratlerdsiri, Weerachai, van Zyl, Smit, Bornman, M. S. Riana, Mercer, Tim R. and Hayes, Vanessa M. (2019). TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: a focus on Africa. Prostate, 79 (10), 1191-1196. doi: 10.1002/pros.23823

TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: a focus on Africa

2019

Journal Article

Targeted, high-resolution RNA sequencing of non-coding genomic regions associated with neuropsychiatric functions

Hardwick, Simon A., Bassett, Samuel D., Kaczorowski, Dominik, Blackburn, James, Barton, Kirston, Bartonicek, Nenad, Carswell, Shaun L., Tilgner, Hagen U., Loy, Clement, Halliday, Glenda, Mercer, Tim R., Smith, Martin A. and Mattick, John S. (2019). Targeted, high-resolution RNA sequencing of non-coding genomic regions associated with neuropsychiatric functions. Frontiers in Genetics, 10 (APR) 309. doi: 10.3389/fgene.2019.00309

Targeted, high-resolution RNA sequencing of non-coding genomic regions associated with neuropsychiatric functions

2019

Journal Article

Natural and regenerated saltmarshes exhibit similar soil and belowground organic carbon stocks, root production and soil respiration

Santini, Nadia S., Lovelock, Catherine E., Hua, Quan, Zawadzki, Atun, Mazumder, Debashish, Mercer, Tim R., Muñoz-Rojas, Miriam, Hardwick, Simon A., Madala, Bindu Swapna, Cornwell, William, Thomas, Torsten, Marzinelli, Ezequiel M., Adam, Paul, Paul, Swapan and Vergés, Adriana (2019). Natural and regenerated saltmarshes exhibit similar soil and belowground organic carbon stocks, root production and soil respiration. Ecosystems, 22 (8), 1803-1822. doi: 10.1007/s10021-019-00373-x

Natural and regenerated saltmarshes exhibit similar soil and belowground organic carbon stocks, root production and soil respiration

2019

Journal Article

Crizotinib and surgery for long-term disease control in children and adolescents with ALK-positive inflammatory myofibroblastic tumors

Trahair, Toby, Gifford, Andrew J., Fordham, Ashleigh, Mayoh, Chelsea, Fadia, Mitali, Lukeis, Robyn, Wood, Andrew C., Valvi, Santosh, Walker, Roderick D., Blackburn, James, Heyer, Erin E., Mercer, Tim R., Barbaric, Draga, Marshall, Glenn M. and MacKenzie, Karen L. (2019). Crizotinib and surgery for long-term disease control in children and adolescents with ALK-positive inflammatory myofibroblastic tumors. JCO Precision Oncology, 3 (3), 1-11. doi: 10.1200/PO.18.00297

Crizotinib and surgery for long-term disease control in children and adolescents with ALK-positive inflammatory myofibroblastic tumors

2018

Journal Article

Synthetic microbe communities provide internal reference standards for metagenome sequencing and analysis

Hardwick, Simon A., Chen, Wendy Y., Wong, Ted, Kanakamedala, Bindu S., Deveson, Ira W., Ongley, Sarah E., Santini, Nadia S., Marcellin, Esteban, Smith, Martin A., Nielsen, Lars K., Lovelock, Catherine E., Neilan, Brett A. and Mercer, Tim R. (2018). Synthetic microbe communities provide internal reference standards for metagenome sequencing and analysis. Nature Communications, 9 (1) 3096, 3096. doi: 10.1038/s41467-018-05555-0

Synthetic microbe communities provide internal reference standards for metagenome sequencing and analysis

2018

Journal Article

Machine learning annotation of human branchpoints

Signal, Bethany, Gloss, Brian S., Dinger, Marcel E. and Mercer, Tim R. (2018). Machine learning annotation of human branchpoints. Bioinformatics, 34 (6), 920-927. doi: 10.1093/bioinformatics/btx688

Machine learning annotation of human branchpoints

2018

Journal Article

Universal Alternative Splicing of Noncoding Exons

Deveson, Ira W., Brunck, Marion E., Blackburn, James, Tseng, Elizabeth, Hon, Ting, Clark, Tyson A., Clark, Michael B., Crawford, Joanna, Dinger, Marcel E., Nielsen, Lars K., Mattick, John S. and Mercer, Tim R. (2018). Universal Alternative Splicing of Noncoding Exons. Cell Systems, 6 (2), 245-255. doi: 10.1016/j.cels.2017.12.005

Universal Alternative Splicing of Noncoding Exons

2017

Journal Article

Intergenic disease-associated regions are abundant in novel transcripts

Bartonicek, N., Clark, M. B., Quek, X. C., Torpy, J. R., Pritchard, A. L., Maag, J. L. V., Gloss, B. S., Crawford, J., Taft, R. J., Hayward, N. K., Montgomery, G. W., Mattick, J. S., Mercer, T. R. and Dinger, M. E. (2017). Intergenic disease-associated regions are abundant in novel transcripts. Genome biology, 18 (241) 241, 241. doi: 10.1186/s13059-017-1363-3

Intergenic disease-associated regions are abundant in novel transcripts

2017

Journal Article

Phosphoproteomic profiling reveals ALK and MET as novel actionable targets across synovial sarcoma subtypes

Fleuren, Emmy D. G., Vlenterie, Myrella, Van Der Graaf, Winette T. A., Hillebrandt-Roeffen, Melissa H. S., Blackburn, James, Ma, Xiuquan, Chan, Howard, Magias, Mandy C., Van Erp, Anke, Van Houdt, Laurens, Cebeci, Sabri A. S., Van De Ven, Amy, Flucke, Uta E., Heyer, Erin E., Thomas, David M., Lord, Christopher J., Marini, Kieren D., Vaghjiani, Vijesh, Mercer, Tim R., Cain, Jason E., Wu, Jianmin, Versleijen-Jonkers, Yvonne M. H. and Daly, Roger J. (2017). Phosphoproteomic profiling reveals ALK and MET as novel actionable targets across synovial sarcoma subtypes. Cancer Research, 77 (16), 4279-4292. doi: 10.1158/0008-5472.CAN-16-2550

Phosphoproteomic profiling reveals ALK and MET as novel actionable targets across synovial sarcoma subtypes

2017

Journal Article

Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage

Betts, Joshua A., Moradi Marjaneh, Mahdi, Al-Ejeh, Fares, Lim, Yi Chieh, Shi, Wei, Sivakumaran, Haran, Tropee, Romain, Patch, Ann.-Marie, Clark, Michael B., Bartonicek, Nenad, Wiegmans, Adrian P., Hillman, Kristine M., Kaufmann, Susanne, Bain, Amanda L., Gloss, Brian S., Crawford, Joanna, Kazakoff, Stephen, Wani, Shivangi, Wen Shu W., Day, Bryan, Moller, Andreas, Cloonan, Nicole, Pearson,John, Brown, Melissa A., Mercer, Timothy R., Waddell, Nicola, Khanna, Kum Kum, Dray, Eloise, Dinger, Marcel E. ... French, Juliet D. (2017). Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage. American Journal of Human Genetics, 101 (2), 255-266. doi: 10.1016/j.ajhg.2017.07.007

Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage

2017

Journal Article

Reference standards for next-generation sequencing

Hardwick, Simon A., Deveson, Ira W. and Mercer, Tim R. (2017). Reference standards for next-generation sequencing. Nature Reviews Genetics, 18 (8), 473-484. doi: 10.1038/nrg.2017.44

Reference standards for next-generation sequencing

2017

Journal Article

The dimensions, dynamics, and relevance of the mammalian noncoding transcriptome

Deveson, Ira W., Hardwick, Simon A., Mercer, Tim R. and Mattick, John S. (2017). The dimensions, dynamics, and relevance of the mammalian noncoding transcriptome. Trends in Genetics, 33 (7), 464-478. doi: 10.1016/j.tig.2017.04.004

The dimensions, dynamics, and relevance of the mammalian noncoding transcriptome

2017

Journal Article

ANAQUIN: a software toolkit for the analysis of spike-in controls for next generation sequencing

Wong, Ted, Deveson, Ira W., Hardwick, Simon A. and Mercer, Tim R. (2017). ANAQUIN: a software toolkit for the analysis of spike-in controls for next generation sequencing. Bioinformatics, 33 (11), 1723-1724. doi: 10.1093/bioinformatics/btx038

ANAQUIN: a software toolkit for the analysis of spike-in controls for next generation sequencing

2016

Journal Article

Spliced synthetic genes as internal controls in RNA sequencing experiments

Hardwick, Simon A., Chen, Wendy Y., Wong, Ted, Deveson, Ira W., Blackburn, James, Andersen, Stacey B., Nielsen, Lars K., Mattick, John S. and Mercer, Tim R. (2016). Spliced synthetic genes as internal controls in RNA sequencing experiments. Nature Methods, 13 (9), 792-798. doi: 10.1038/nmeth.3958

Spliced synthetic genes as internal controls in RNA sequencing experiments

2016

Journal Article

Representing genetic variation with synthetic DNA standards

Deveson, Ira W., Chen, Wendy Y., Wong, Ted, Hardwick, Simon A., Andersen, Stacey B., Nielsen, Lars K., Mattick, John S. and Mercer, Tim R. (2016). Representing genetic variation with synthetic DNA standards. Nature Methods, 13 (9), 784-791. doi: 10.1038/nmeth.3957

Representing genetic variation with synthetic DNA standards

2016

Journal Article

Improved definition of the mouse transcriptome via targeted RNA sequencing

Bussotti, Giovanni, Leonardi, Tommaso, Clark, Michael B., Mercer, Tim R., Crawford, Joanna, Malquori, Lorenzo, Notredame, Cedric, Dinger, Marcel E., Mattick, John S. and Enright, Anton J. (2016). Improved definition of the mouse transcriptome via targeted RNA sequencing. Genome Research, 26 (5), 705-716. doi: 10.1101/gr.199760.115

Improved definition of the mouse transcriptome via targeted RNA sequencing

Funding

Current funding

  • 2026 - 2031
    IMPACT: Immunocellular Manufacturing Platform for Advanced Cell Therapies
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2025 - 2028
    Improving Quality Control of mRNA Manufacture with Nanopore Sequencing
    ARC Linkage Projects
    Open grant
  • 2024 - 2029
    Building mRNA Cancer Vaccines for Australia.
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2024 - 2029
    Australian Centre for RNA Therapeutics in Cancer (CRT Collaborative Cancer Research Grant - 2023 administered by University of Western Australia)
    University of Western Australia
    Open grant
  • 2023 - 2028
    Translational ecosystem for clinical development of mRNA modalities (MRFF mCTEI externally led by Southern RNA)
    Southern RNA PTY LTD
    Open grant
  • 2023 - 2028
    Base - NCRIS 2022 (administered by the Therapeutic Innovation Australia (TIA))
    Therapeutic Innovation Australia Limited
    Open grant
  • 2023 - 2028
    Building the next mRNA vaccines and therapies
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2023 - 2027
    Building RNA therapies to re-program gene expression.
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2024
    Conjugation of targeting protein moieties to non-viral vectors such as lipid nanoparticles (LNPs) (University College London administered UKRI BBSRC grant)
    University College London
    Open grant
  • 2023 - 2024
    Optimisation of mRNA production and purification using the AMBR15 and AMBRCF
    Innovation Connections
    Open grant
  • 2022 - 2024
    Building Synthetic DNA Controls for Oxford Nanopore Sequencing
    NHMRC Development Grant
    Open grant
  • 2011 - 2012
    Receptor-specific targeting of extracellular RNA to recipient cells
    UQ Early Career Researcher
    Open grant

Supervision

Availability

Professor Timothy Mercer is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Professor Timothy Mercer's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au